Actinogen Medical (ACW) 2015年年度报告「ASX」.pdf

1、 ACTINOGEN LIMITED ABN 14 086 778 476 FINANCIAL STATEMENTS YEAR ENDED 30 JUNE 2015 ACTINOGEN LIMITED C O N T E N T S P A G E Contents Page Corporate Directory 2 Corporate Governance Statement 3 Directors Report 11 Lead Auditors Independence Declaration 36 Consolidated Statement of Comprehensive Inco

2、me 37 Consolidated Statement of Financial Position 38 Consolidated Statement of Cash Flows 39 Consolidated Statement of Changes in Equity 40 Notes to the Financial Statements 41 Directors Declaration 73 Independent Auditors Report 74 Shareholder Information 76 ACTINOGEN LIMITED C O R P O R A T E D I

3、 R E C T O R Y 2 Board of DirectorsAuditorsExecutive Chairman Mr Martin RogersErnst&YoungManaging Director Dr Bill KetelbeyErnst&Young BuildingNon-Executive Director Dr Jason Loveridge11 Mounts Bay RoadNon-Executive Director Dr Anton UvarovPerth WA 6000Company SecretaryLawyersCompany Secretary-Peter

4、 WebseGTP LegalLevel 1,28 Ord Street Principal Place of Business/Registered OfficeWest Perth WA 6005Level 9,Suite 1,68 Pitt StreetSydney NSW 2000Share RegisterAutomic Registry ServicesPostal AddressSuite 1A,Level 1PO Box 2717 Ventnor AvenueWest Perth WA 6872West Perth WA 6005Contact DetailsActinogen

5、 Limited shares are listed onTelephone:02 8964 7401the Australian Stock Exchange(ASX).auASX Code:ACWABN 14 086 778 476BankersNational Australia Bank1232 Hay StreetWest Perth WA 6005ACTINOGEN LIMITED C O R P O R A T E G O V E R N A N C E S T A T E M E N T _ 3 This Corporate Governance Statement(“Stat

6、ement”)outlines the key aspects of Actinogen Limiteds(Actinogen or the Company)governance framework and main governance practices.The Companys charters,policies,and procedures are regularly reviewed and updated to comply with law and best practice.These charters and policies can be viewed on Actinog